Why did the Serbian military offer to fly Prof. Farhad Hafezi in a helicopter to a ski resort in early September? After all, the slopes were green with grass, not white with snow.
Presenting to the Swiss Optometrists Association (SBAO) Annual Meeting, Hafezi identified the single biggest villain in the development of keratoconus: eye rubbing.
Children: to cross-link or not to cross-link? If a person is going to develop keratoconus, that person is more likely to be a child than an adult.
Keratoconus is the progressive thinning of the cornea, and corneal cross-linking (CXL) can successfully treat it.
Prof. Hafezi in a video interview with EyeWorld at the World Ophthalmology Congress 2018 in Barcelona about the relationship between thyroid hormone and changes in the cornea and in vision.
Algorithm predicts CXL effect: in this scientific article, we published a new algorithm that combines the knowledge we accumulated over the past 12 years
Cataract & Refractive Surgery Today Europe April 2017: ELZA member and EMAGine CEO Nikki Hafezi describes the technique of CXL at the slit lamp
The ELZA founder Farhad Hafezi gives an invited lecture on “Past, Present and Future of Cross-Linking”
We are currently developing the technique of slit lamp cross-linking, one crucial step will be to determine whether riboflavin, once applied onto the cornea, remains at saturation levels during a CXL procedure
“Sitting down with” is an interview series of the journal The Ophthalmologist covering selected personalities in ophthalmology.
